Several studies have estimated the costeffectiveness of GLP1s for obesity from a healthcare perspective, considering costs for screening and treatment against savings from improved weight and health outcomes and corresponding longterm reductions in healthcare utilization, including downstream accumulated health benefits
For an existing comparison based on separate trials, see our retatrutide vs tirzepatide analysis
This improves weight loss results
Obesity: a much higher study focus than other metabolic disease areas Precisely classifying the clinical trial types in the metabolic domain can be a fraught affair given the variability of descriptions, but taking a conservative approach to classification clearly reveals that trials involving obesity and overweight outnumber those focused more on type 2 diabetes about four to one
(PubMed) DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH
Your nerves may also be affected, causing tingling in the hands or feet and changes in mood
